Search This Blog

Tuesday, March 17, 2026

HSBC downgrades Eli Lilly to Reduce, cuts price target to $850 from $1,070

 


  • HSBC cites expected 2026 obesity price cuts as a headwind despite management’s volume growth guidance.
Posted by at

No comments:

Post a Comment

Note: Only a member of this blog may post a comment.

Subscribe to: Post Comments (Atom)